October 01, 2014 8:40 PM ET

Healthcare Equipment and Supplies

Company Overview of Provista Diagnostics, Inc.

Company Overview

Provista Diagnostics, Inc. develops and commercializes blood-based diagnostic tests for early oncology-related disease state recognition and detection. It focuses on women's cancers such as breast and ovarian cancer. The company offers dtectDx Breast, a blood test for detection of early breast cancer development. Additionally, it provides contract laboratory services to the molecular diagnostic and pharmaceutical industries. Provista Diagnostics, Inc. was founded in 2007 and is based in Scottsdale, Arizona.

17301 North Perimeter Drive

Scottsdale, AZ 85255

United States

Founded in 2007

Phone:

602-224-5500

Fax:

602-391-2101

Key Executives for Provista Diagnostics, Inc.

Chief Executive Officer and President
Age: 42
Chief Operating Officer
Chief Commercial Officer
Clinical Laboratory Director
Compensation as of Fiscal Year 2014.

Provista Diagnostics, Inc. Key Developments

Provista Diagnostics Completes Enrollment of its 001 Prospective Study of Protein-Based Biomarker Blood Test to Aid in Detection of Breast Cancer

Provista Diagnostics, Inc. announced that the final patient has been enrolled in a prospective, blinded, randomized study of Provista's proteomic breast cancer detection test. The 001 study is designed to utilize Provista's proprietary blood test in conjunction with standard of care to help assess the presence of breast cancer in patients with suspicious breast lesions. The trial enrolled 351 women, 25 to 49 years of age who were classified under the Breast Imaging-Reporting and Data System (BI-RADS(R)) Assessment Category 3 or 4. BI-RAD 3 patients are defined as women with lesions that are probably benign and Assessment Category 4, defined as suspicious for malignancy. Women under the age of 50 were specifically enrolled due to the limitations of current detection modalities for women in this age group. Additionally, cancers found in women under the age of 50 have been shown to be more aggressive. Provista's test is used in conjunction with a BI-RADS 3 or 4 classification, which is based on suspicious anatomical changes, by providing further evidence as to the biochemical signature of the individual patient. By providing both biochemical and anatomic information to physicians, the goal is to precisely inform whether the patient should undergo biopsy, further imaging studies or a 6-month follow-up.

Provista Diagnostics, Inc. Appoints Rao V. Mulpuri as Chief Operating Officer

Provista Diagnostics, Inc. announced the appointment of Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer (COO). In this role, Dr. Mulpuri will be responsible for leading and managing all aspects of the company's operations, including integration of the scientific and business functions, as well as quality and regulatory oversight to support the launch of Provista's pipeline of products. Most recently, Dr. Mulpuri served as Vice President of Laboratory Operations for AssureRx Health, Inc.

Provista Diagnostics, Inc. Presents at Rodman & Renshaw 16th Annual Global Investment Conference, Sep-10-2014 02:30 PM

Provista Diagnostics, Inc. Presents at Rodman & Renshaw 16th Annual Global Investment Conference, Sep-10-2014 02:30 PM. Venue: New York Palace Hotel – 455 Madison Avenue, New York, NY 10022, United States. Speakers: David E. Reese, Chief Executive Officer and President.

Similar Private Companies By Industry

Company Name Region
Medtronic Spine LLC United States
ProCare Medical Supply Co., Inc. United States
FUJIFILM SonoSite, Inc. United States
Visus Techonology, Inc. United States
3Scan, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 8, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Provista Diagnostics, Inc., please visit www.provistadx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.